POZ - POZ Magazine - POZ.com - News : IAC: Tibotec VP Discusses Latest On Prezista

Most Popular Lessons
	The HIV Life Cycle Shingles Herpes Simplex Virus Syphilis & Neurosyphilis Treatments for Opportunistic Infections (OIs) What is AIDS & HIV? Hepatitis & HIV

10 Years Ago In POZ
	Woman on the Verge The River Runs Through It The Jelly Revolution Let's Dance » Full Issue

More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

August 16, 2006

IAC: Tibotec VP Discusses Latest On Prezista

by Peter Staley

AIDSmeds Founder Peter Staley interviewed Dr. Alan Tennenberg, Tibotec's VP of Clinical Affairs, regarding the latest clinical data on Prezista, the newly approved protease inhibitor. We also asked him about how the company responded to community demands around pricing.

Click here to listen to the 7 minute interview.
(6.4MB mp3 file)

[Go to top]

Quick Links

	Current Issue


	HIV 101
	HIV Testing
	Safer Sex
	Find a Date
	Newly Diagnosed

	Disclosing Your Status
	POZ TV
	Read the Blogs
	Visit the Forums
	Women
	African American
	Latino
	Community
	Advocacy
	Job Listings
	Events Calendar
	Starting Treatment
	My Cool Tools

DJ10465
Bronx
New York

whatnow22
Orlando
Florida

nsentarian
blasdell
New York

ifeekes
san antonio
Texas

Click here to join POZ Personals!

Talk to Us

Poll

Survey

Peace of Mind

We welcome your comments!

[ about Smart + Strong \| about POZ \| POZ advisory board \| partner links \| advertising policy \| advertise/contact us \| site map]

© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy